1. Home
  2. PCVX vs ULS Comparison

PCVX vs ULS Comparison

Compare PCVX & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • ULS
  • Stock Information
  • Founded
  • PCVX 2013
  • ULS 1894
  • Country
  • PCVX United States
  • ULS United States
  • Employees
  • PCVX N/A
  • ULS N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • ULS
  • Sector
  • PCVX Health Care
  • ULS
  • Exchange
  • PCVX Nasdaq
  • ULS Nasdaq
  • Market Cap
  • PCVX 4.0B
  • ULS 14.6B
  • IPO Year
  • PCVX 2020
  • ULS 2024
  • Fundamental
  • Price
  • PCVX $32.59
  • ULS $68.02
  • Analyst Decision
  • PCVX Strong Buy
  • ULS Buy
  • Analyst Count
  • PCVX 8
  • ULS 8
  • Target Price
  • PCVX $114.17
  • ULS $69.25
  • AVG Volume (30 Days)
  • PCVX 1.6M
  • ULS 713.6K
  • Earning Date
  • PCVX 11-04-2025
  • ULS 11-04-2025
  • Dividend Yield
  • PCVX N/A
  • ULS 0.76%
  • EPS Growth
  • PCVX N/A
  • ULS 21.42
  • EPS
  • PCVX N/A
  • ULS 1.62
  • Revenue
  • PCVX N/A
  • ULS $2,951,000,000.00
  • Revenue This Year
  • PCVX N/A
  • ULS $6.69
  • Revenue Next Year
  • PCVX N/A
  • ULS $6.21
  • P/E Ratio
  • PCVX N/A
  • ULS $42.12
  • Revenue Growth
  • PCVX N/A
  • ULS 6.92
  • 52 Week Low
  • PCVX $27.66
  • ULS $48.11
  • 52 Week High
  • PCVX $121.06
  • ULS $74.15
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 53.03
  • ULS 56.68
  • Support Level
  • PCVX $31.47
  • ULS $66.17
  • Resistance Level
  • PCVX $33.16
  • ULS $68.43
  • Average True Range (ATR)
  • PCVX 1.37
  • ULS 1.82
  • MACD
  • PCVX 0.07
  • ULS 0.60
  • Stochastic Oscillator
  • PCVX 67.76
  • ULS 93.41

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

Share on Social Networks: